Literature DB >> 8195639

Reliability of pancreatic cancer staging classifications.

A Zerbi1, G Balzano, R Bottura, V Di Carlo.   

Abstract

The prognostic value of UICC and JPS classifications was evaluated in a group of 74 patients undergoing resection for pancreatic carcinoma in the 1982-1992 period. The predictivity of peritoneal cytology and intraoperative liver biopsies was evaluated in a subgroup of 15 patients. Patient division by stage according, respectively, to UICC and JPS classifications was: stage I: 28 and 2 patients; stage II: 12 and 11 patients; stage III: 29 and 30 patients; stage IV: 5 and 31 patients. Median survival by UICC stages was: 17 months (m) in stage I, 10 m in stage II, 12 m in stage III, and 6 m in stage IV; by JPS stages it was 29 m in stage II, 14 m in stage III, and 7 m in stage IV. A radical resection was possible in 48 patients (65%); the survival was significantly worse in the nonradical resection group. The survival difference among UICC stages was not significant in a multivariate analysis with radicality, whereas among JPS stages a significant survival difference was found in both univariate and multivariate analysis. The tumor invasion of the retroperitoneal tissues and the presence of distant metastasis were indicators of a significantly worse prognosis. Lymph node involvement, tumor size, and serosal invasion had no significant effect on survival. Peritoneal cytology and liver biopsies did not provide further prognostic information.

Entities:  

Mesh:

Year:  1994        PMID: 8195639     DOI: 10.1007/bf02924383

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  14 in total

1.  Staging of cancer of the pancreas.

Authors:  J E Trapnell
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

2.  UICC and Japanese stage classifications for carcinoma of the pancreas.

Authors:  T Tsunoda; K Ura; T Eto; T Matsumoto; R Tsuchiya
Journal:  Int J Pancreatol       Date:  1991-04

3.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

4.  Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality.

Authors:  M Trede; G Schwall; H D Saeger
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

Review 5.  Pancreatic cancer in 1988. Possibilities and probabilities.

Authors:  A L Warshaw; R S Swanson
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

6.  Multivariate survival analysis using Cox's regression model.

Authors:  E Christensen
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

7.  Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreas.

Authors:  A S Hermreck; C Y Thomas; S R Friesen
Journal:  Am J Surg       Date:  1974-06       Impact factor: 2.565

8.  Patterns of failure after curative resection of pancreatic carcinoma.

Authors:  J F Griffin; S R Smalley; W Jewell; J C Paradelo; R D Reymond; R E Hassanein; R G Evans
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

9.  Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.

Authors:  C G Willett; K Lewandrowski; A L Warshaw; J Efird; C C Compton
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

10.  Implications of peritoneal cytology for staging of early pancreatic cancer.

Authors:  A L Warshaw
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

View more
  7 in total

Review 1.  The role of endoscopic ultrasound in pancreatic disorders.

Authors:  W R Brugge
Journal:  Int J Pancreatol       Date:  1996-08

2.  Evaluation of UICC TNM classification for pancreatic cancer. A study of 228 patients.

Authors:  G Balzano; C Bassi; A Zerbi; M Falconi; G Calori; G Butturini; B E Leone; P Pederzoli; V Di Carlo
Journal:  Int J Pancreatol       Date:  1997-04

Review 3.  Results of adjuvant therapy in resected pancreatic cancer.

Authors:  A Andrén-Sandberg; P L Bäckman; R Andersson
Journal:  Int J Pancreatol       Date:  1997-02

4.  Staging of pancreatic cancer: suggestions for a simplified, reliable modification of the TNM classification system.

Authors:  C Bassi; G Butturini; M Falconi; C Iacono; G Serio; P Pederzoli
Journal:  Int J Pancreatol       Date:  1995-04

5.  A study of malabsorption in pancreatic cancer.

Authors:  H Wakasugi; Y Hara; M Abe
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

6.  Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.

Authors:  G M Fuhrman; S D Leach; C A Staley; J C Cusack; C Charnsangavej; K R Cleary; A K El-Naggar; C J Fenoglio; J E Lee; D B Evans
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

7.  Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: relevance to indicator of better prognosis.

Authors:  H Suwa; G Ohshio; S Arao; T Imamura; K Yamaki; T Manabe; M Imamura; H Hiai; M Fukumoto
Journal:  Jpn J Cancer Res       Date:  1996-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.